Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours

Oncogene

Volumn 15, Issue 17, 1997, Pages 2119-2126

  Gayther, Simon A ^a   Barski, Piotr ^a   Batley, Sarah J ^b   Li, Limin ^c   De Foy, Karen A F ^a   Cohen, Stanley N ^c   Ponder, Bruce A J ^a,b   Caldas, Carlos ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

FHIT; Splicing; TSG101; Tumour

Indexed keywords

MESSENGER RNA;

ARTICLE; B LYMPHOCYTE; CANCER INHIBITION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; LUNG PARENCHYMA; MULTIPLE CANCER; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RNA SPLICING; RNA TRANSCRIPTION; TUMOR SUPPRESSOR GENE;

HUMAN HERPESVIRUS 4;

EID: 0030698051     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201591     Document Type: Article

References (17)

1. Druck T, Hadaczek P, Fu T-B, Ohta M, Siprashvili Z, Baffa R, Negrini M, Kastury K, Veronese ML, Rosen D, Rothstein J, McCue P, Cotticelli MG, Inoue H, Croce CM and Huebner K. (1997). Cancer Res., 57, 504-512.
2. Flaman J-M, Waridel F, Estreicher A, Vannier A, Limacher J-M, Gilbert D, Iggo R and Frebourg T. (1996). Oncogene, 12, 813-818.
3. Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Bader SA, Ahmadian M, Ong ST, Rassool FY, Zimmerman PV, Giaccone G, Gazdar AF and Minna JD. (1997). Cancer Res., 57, 2256-2267.
4. Foster KA, Harrington PA, Kerr J, Russell PA, DiCiocco RA, Scott IV, Jacobs I, Chenevix-Trench G, Ponder BAJ and Gayther SA. (1996). Cancer Res., 56, 3622-3625.
5. Gayther SA, Mangion J, Russell P, Seal S, Barfoot R, Ponder BAJ, Stratton M and Easton D. (1997). Nature Genetics, 15, 103-105.
6. Hayashi S-I, Tanimoto K, Hajiro-Nakanishi K, Tsuchiya E, Kurosumi M, Higashi Y, Imai K, Suga K and Nakachi K. (1997). Cancer Res., 57, 1981-1985.
7. Huebner K, Hadaczek P, Siprashvili Z, Druck T and Croce CM. (1997). Biochim. Biophys. Acta, 1332, M65-M70.
8. Lee MP and Feinberg AP. (1997). Cancer Res., 57, 3131-3134.
9. Li L and Cohen SN. (1996). Cell, 85, 319-329.
10. Li L, Li X, Francke U and Cohen SN. (1997). Cell, 88, 143-154.
11. Locher K, Siegler G, Fuhrer M, Greil J, Beck JD, Fey GH and Marschalek R. (1996). Cancer Res., 56, 2171-2177.
12. Luan X, Shi G, Zohouri M, Paradee W, Smith DI, Decker HJ and Cannizzaro LA. (1997). Oncogene, 15, 79-86.
13. Nam DK, Honoki K, Yu M and Yunis JJ. (1996). Gene, 178, 169-175.
14. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM and Huebner K. (1996). Cell, 84, 587-597.
15. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, Inoue H, Tornielli S, Pilotti S, De Gregorio L, Pastorino U, Pierotti MA, Ohta M, Huebner K and Croce CM. (1996). Cell, 85, 17-26.
16. Steiner P, Barnes DM, Harris WH and Weinberg RA. (1997). Nature Genetics, 16, 332-333.
17. Virgilio L, Shuster M, Gollin SM, Veronese ML, Ohta M, Huebner K and Croce CM. (1996). Proc. Nat. Acad. Sci. USA, 93, 9770-9775.